Can-Fite BioPharma (NYSE:CANF) Now Covered by StockNews.com
StockNews.com initiated coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research note issued to investors on Saturday. The firm issued a hold rating on the stock. Separately, HC Wainwright reduced their target price on shares of Can-Fite BioPharma from $34.00 to $18.00 and set a buy rating on the stock in […]
More Stories
Harrow (NASDAQ:HROW) Shares Down 3.6% – What’s Next?
Harrow, Inc. (NASDAQ:HROW – Get Free Report)’s share price dropped 3.6% during trading on Monday . The stock traded as...
SoFi Technologies (NASDAQ:SOFI) Trading 1.2% Higher – Still a Buy?
Shares of SoFi Technologies, Inc. (NASDAQ:SOFI – Get Free Report) shot up 1.2% on Monday . The company traded as...
Alphabet (NASDAQ:GOOGL) Trading 1.9% Higher – Time to Buy?
Alphabet Inc. (NASDAQ:GOOGL – Get Free Report)’s stock price rose 1.9% during mid-day trading on Monday . The stock traded...
Archer Aviation (NYSE:ACHR) Shares Up 26.5% – Still a Buy?
Archer Aviation Inc. (NYSE:ACHR – Get Free Report)’s stock price rose 26.5% during mid-day trading on Monday . The stock...
MultiMetaVerse Holdings Limited (NASDAQ:MMV) Sees Large Increase in Short Interest
MultiMetaVerse Holdings Limited (NASDAQ:MMV – Get Free Report) was the recipient of a significant increase in short interest in November....
Short Interest in Harvia Oyj (OTCMKTS:HRVFF) Grows By 300.0%
Harvia Oyj (OTCMKTS:HRVFF – Get Free Report) was the recipient of a large growth in short interest during the month...